ClinicalTrials.gg
Enrolling by invitationNCT07930962Updated Nov 12, 2026

The Effectiveness of Wearable Technology-Supported Gamification in Reducing Pain and Anxiety During Medical Procedures in Children: A Randomized Controlled Trial

An interventional study of Wearable Technology-Supported Gamification in Procedural Pain and Procedural Anxiety, sponsored by Bulent Ecevit University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Bulent Ecevit University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2026, registered Oct 2026).
Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 79 studies in Pain, Procedural with a site in Turkey — 14 open to participants now, 14 under way, none of them phase 3. Pain, Procedural · Turkey.

Planned enrollment
69th of 77
60 · median 100
Started
2026
with 18 others
No phase
75 of 79
13 open now
Primary completion
2026-12
later than 7 of 13 live
Registered
76th of 79
by date

Among the 79 studies in Pain, Procedural with a site in Turkey, this one is the 69th largest by planned enrollment of the 77 interventional ones that give a count, is one of 19 that started in 2026, is one of 75 with no phase, reaches primary completion later than 7 of the 13 other live ones, and was the 76th registered.

Pain, Procedural

241 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

Browse Pain, Procedural studies →

Open to participants now

14 of the 79 studies in Pain, Procedural with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 29 Pain, Procedural studies recruiting now, 13 (45%) set no upper age limit and 14 (48%) stop at 75 or younger; 14 take children under 18; 5 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Pain, Procedural with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effectiveness of wearable technology-supported gamification in reducing pain and anxiety and its effects on heart rate in children aged 6-12 years undergoing venous blood sampling or peripheral intravenous catheterization.

Medical procedures may cause pain, fear, and anxiety in children and can affect their cooperation during treatment. Distraction through age-appropriate digital activities may help children cope with these experiences. This study will investigate whether combining a smart wristband with an interactive digital storytelling activity is more effective than standard care in reducing pain and anxiety during medical procedures.

A total of 60 children will be included in the study, with 30 children assigned to the intervention group and 30 to the control group. Group allocation will be performed using a randomization procedure involving sealed envelopes containing group assignment cards.

Children in the intervention group will wear a smart wristband and participate in an interactive, space-themed digital storytelling activity presented on a tablet. The activity will include age-appropriate story elements and simple interactive tasks, such as touching targets or popping balloons, to redirect children's attention during the procedure. The story will guide children through different stages of the activity, from the beginning of the mission to its completion. At the end of the procedure, children will receive a positive reinforcement sticker. Children in the control group will receive standard nursing care without the gamification intervention.

Pain will be assessed using the Wong-Baker FACES Pain Rating Scale, and anxiety will be evaluated using the Modified Yale Preoperative Anxiety Scale. Heart rate will be recorded before, during, and after the procedure. The outcomes will be compared between the intervention and control groups.

The study hypothesis is that wearable technology-supported gamification will be associated with lower pain and anxiety levels and lower heart rates during invasive medical procedures compared with standard care. The study will also examine whether this approach may help improve children's cooperation during the procedures.

Read the detailed description

This randomized controlled interventional study aims to evaluate the effectiveness of wearable technology-supported gamification during invasive medical procedures in children. The intervention combines a smart wristband with an interactive, space-themed digital storytelling activity designed to redirect children's attention and support their cooperation during venous blood sampling and peripheral intravenous catheterization.

The study will include 60 children, with 30 participants planned for the intervention group and 30 for the control group. Participants will be allocated to the groups using a randomization procedure involving sealed envelopes containing group assignment cards.

Intervention Group

The intervention will be implemented in three stages: before, during, and after the medical procedure.

Before the procedure, the researcher will meet with the child and parent or legal guardian, explain the study, and obtain the required consent and assent. The child's anxiety will be assessed using the Modified Yale Preoperative Anxiety Scale. A smart wristband will then be placed on the child's wrist, and baseline heart rate will be recorded.

During the procedure, the child will participate in an interactive, space-themed digital storytelling activity presented on a tablet. The activity will be designed to engage the child through a mission-based narrative and age-appropriate interactive tasks. The story will include stages such as "Welcome to the Space Station," "Put on Your Super Shield," "Collect Stardust," and "Mission Completed, Energy Recharged."

The child will be encouraged to participate as a space explorer. While the healthcare professional prepares for and performs the medical procedure, the child will be guided through simple digital activities, such as popping balloons or touching interactive targets on the tablet. The smart wristband will be incorporated into the story as part of the child's "superpower" experience. Heart rate will be monitored and recorded before, during, and after the procedure, including the highest heart rate recorded during the procedure.

After the procedure, the child's anxiety will be reassessed using the Modified Yale Preoperative Anxiety Scale, and pain will be assessed using the Wong-Baker FACES Pain Rating Scale. The child will receive a "Brave Hero" sticker as positive reinforcement at the end of the activity.

Control Group

Children assigned to the control group will receive routine clinical procedures and standard nursing care without the digital gamification activity or the wearable technology-supported intervention. Venous blood sampling and peripheral intravenous catheterization will be performed by experienced healthcare professionals according to routine clinical practice.

Data Collection and Statistical Analysis

Study data will be collected using a researcher-developed Personal Information Form, the Modified Yale Preoperative Anxiety Scale, the Wong-Baker FACES Pain Rating Scale, and heart rate measurements. The personal information form will include demographic and clinical characteristics, details of the medical procedure, previous experiences with similar procedures, the presence of a parent or accompanying person, and previous experience with wearable technology and digital games.

Data will be analyzed using IBM SPSS Statistics. The distribution of the data will be assessed using the Kolmogorov-Smirnov test. Descriptive statistics will include frequencies, percentages, means, and standard deviations, as appropriate. Between-group comparisons will be performed using the independent-samples t-test or the Mann-Whitney U test, depending on the distribution of the data. Appropriate parametric or nonparametric methods will be used to analyze repeated measurements. Statistical significance will be set at p \< 0.05.

Ethical Considerations

Written informed consent will be obtained from parents or legal guardians, and age-appropriate assent will be obtained from participating children. Participant information will be kept confidential and used only for scientific purposes. The child's physical and psychological well-being will be prioritized throughout the study. The intervention will be discontinued if the child experiences excessive pain or distress or if a clinical complication occurs. Routine medical procedures will be performed by experienced healthcare professionals.

03

Conditions studied

  • Procedural Pain
  • Procedural Anxiety

Keywords

  • Child
  • Children
  • Pediatric
  • pain
  • procedural pain
  • anxiety
  • Procedural Anxiety
  • Gamification
  • Venipuncture
  • Peripheral Intravenous Catheterization
  • Heart Rate
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 6-12 years.
  • Children scheduled to undergo venous blood sampling or peripheral intravenous catheterization.
  • Children who are conscious and able to communicate.
  • Children whose parents or legal guardians provide and who agree to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Children with neurological, psychiatric, or developmental conditions that may affect participation or outcome assessment.
  • Children with sensory impairments that interfere with seeing, hearing, or communicating during the intervention.
  • Children who are unconscious or unable to communicate.
  • Children requiring emergency procedures.
  • Children who have received analgesic, sedative, or anxiolytic medication before the procedure.
  • Children who do not agree to participate or whose parents or legal guardians do not provide .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Wearable Technology-Supported Gamification

    articipants in this group will receive standard nursing care and wearable technology-supported gamification during venous blood sampling or peripheral intravenous catheterization. The intervention will include wearing a smart wristband and participating in an interactive, space-themed digital storytelling activity presented on a tablet to redirect attention during the medical procedure.

    Behavioral: Wearable Technology-Supported Gamification

  • No intervention
    Standard Nursing Care

    Participants in this group will receive routine clinical procedures and standard nursing care during venous blood sampling or peripheral intravenous catheterization, without the wearable technology-supported gamification intervention.

Interventions

  • BehavioralWearable Technology-Supported Gamification

    The intervention combines a smart wristband with an interactive, space-themed digital storytelling and gamification activity presented on a tablet. During venous blood sampling or peripheral intravenous catheterization, children will be encouraged to participate in age-appropriate interactive tasks, such as popping balloons or touching targets, to redirect their attention from the medical procedure. The activity will follow a mission-based story with stages from the beginning to the completion of the mission. Heart rate will be recorded before, during, and after the procedure using the study's planned measurement methods.

06

What researchers measure

Primary outcomes

  1. Pain Intensity Measured by the Wong-Baker FACES Pain Rating Scale

    Pain intensity will be assessed using the Wong-Baker FACES Pain Rating Scale. Children will be asked to select the face that best represents their pain intensity. The scale consists of six facial expressions scored as follows: 0 (no hurt), 2 (hurts a little bit), 4 (hurts a little more), 6 (hurts even more), 8 (hurts a whole lot), and 10 (hurts worst). Higher scores indicate greater pain intensity. Pain scores will be compared between the intervention and control groups.

    Time frame: Before and immediately after the medical procedure.

  2. Anxiety Level Measured by the Modified Yale Preoperative Anxiety Scale (mYPAS)

    Children's anxiety levels will be assessed using the Modified Yale Preoperative Anxiety Scale (mYPAS). The scale consists of 22 items across five behavioral categories: activity, vocalizations, emotional expressivity, state of arousal, and use of parents. Each category is scored according to the child's observed behaviors. The category scores are standardized and combined to obtain a total score ranging from 23.33 to 100. Higher scores indicate higher levels of anxiety. Anxiety scores will be recorded before, during, and immediately after the medical procedure and compared between the intervention and control groups.

    Time frame: Before, during, and immediately after the medical procedure.

Secondary outcomes

  1. Heart Rate and Respiratory Rate

    Heart rate and respiratory rate will be measured before, during, and immediately after the medical procedure. In the intervention group, these physiological parameters will also be monitored using a wearable smart wristband, and the maximum values recorded during the procedure will be documented. Measurements will be compared between the intervention and control groups to evaluate physiological responses during the medical procedure.

    Time frame: Before, during, and immediately after the medical procedure.

07

Study locations

1 site
  • Çaycuma District State Hospital
    Zonguldak, Çaycuma 67900, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the study, including demographic characteristics, pain and anxiety scores, and physiological measurements, may be shared with qualified researchers upon reasonable request after publication of the study results, subject to ethical approval and applicable data protection requirements. The study protocol and statistical analysis plan may also be shared. Participant identifying information will not be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: De-identified individual participant data and supporting documents will be available beginning 12 months after publication of the study results. Data will remain available for 5 years.

Access criteria: Qualified researchers may request access to de-identified individual participant data and supporting documents for scientifically sound research purposes. Requests will be reviewed by the principal investigator. Access will be subject to ethical approval where applicable, appropriate data protection measures, and a data-sharing agreement. Participant identifying information will not be shared.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.

Of 141 non-industry interventional studies with no phase under Pain, Procedural, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 6 months is below that.

Counting every sponsor, half of 141 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Nov 12, 2026
StartActual
Jun 15, 2026
Primary completionEst.
Dec 30, 2026
CompletionEst.
Jun 15, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07930962
Lead sponsor
Bulent Ecevit University
Responsible party
Gizem nur Köse (master's student, Bulent Ecevit University) — Principal investigator
First posted
Nov 12, 2026
Start date
Jun 15, 2026
Primary completion
Dec 30, 2026 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion